CORTESI, LAURA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.918
AS - Asia 1.579
EU - Europa 1.438
SA - Sud America 237
AF - Africa 53
OC - Oceania 23
Continente sconosciuto - Info sul continente non disponibili 4
Totale 7.252
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.845
SG - Singapore 492
GB - Regno Unito 408
CN - Cina 351
VN - Vietnam 216
HK - Hong Kong 202
IT - Italia 193
DE - Germania 176
BR - Brasile 175
SE - Svezia 135
FI - Finlandia 96
IE - Irlanda 81
FR - Francia 74
UA - Ucraina 72
RU - Federazione Russa 71
TR - Turchia 57
IN - India 41
ID - Indonesia 36
KR - Corea 34
CA - Canada 31
BG - Bulgaria 24
BD - Bangladesh 23
AU - Australia 22
AR - Argentina 21
MX - Messico 19
ZA - Sudafrica 18
BE - Belgio 17
PL - Polonia 16
PK - Pakistan 15
JP - Giappone 13
MY - Malesia 12
AE - Emirati Arabi Uniti 11
MA - Marocco 11
NL - Olanda 11
ES - Italia 10
VE - Venezuela 10
TH - Thailandia 9
CL - Cile 8
CO - Colombia 8
EC - Ecuador 8
IQ - Iraq 8
PH - Filippine 8
SA - Arabia Saudita 8
AT - Austria 6
EG - Egitto 6
HU - Ungheria 6
SI - Slovenia 6
UZ - Uzbekistan 6
DO - Repubblica Dominicana 5
GR - Grecia 5
LB - Libano 5
NO - Norvegia 5
CZ - Repubblica Ceca 4
IR - Iran 4
LT - Lituania 4
LV - Lettonia 4
PA - Panama 4
AL - Albania 3
CH - Svizzera 3
CR - Costa Rica 3
DZ - Algeria 3
GE - Georgia 3
IL - Israele 3
JO - Giordania 3
KE - Kenya 3
NP - Nepal 3
PY - Paraguay 3
TN - Tunisia 3
TW - Taiwan 3
BH - Bahrain 2
BZ - Belize 2
HN - Honduras 2
KZ - Kazakistan 2
NI - Nicaragua 2
OM - Oman 2
PE - Perù 2
RO - Romania 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
AZ - Azerbaigian 1
BF - Burkina Faso 1
BN - Brunei Darussalam 1
CG - Congo 1
CI - Costa d'Avorio 1
CU - Cuba 1
CY - Cipro 1
DK - Danimarca 1
ET - Etiopia 1
EU - Europa 1
GD - Grenada 1
GN - Guinea 1
GT - Guatemala 1
HR - Croazia 1
JM - Giamaica 1
MD - Moldavia 1
ME - Montenegro 1
MK - Macedonia 1
MN - Mongolia 1
MT - Malta 1
Totale 7.242
Salva come PNG Salva come JPEG
Città #
Fairfield 447
Ashburn 407
Singapore 328
Santa Clara 288
Woodbridge 274
Southend 246
Chandler 216
Seattle 199
Hong Kong 198
Houston 160
Cambridge 156
San Jose 134
Wilmington 128
Dearborn 119
Ann Arbor 113
Beijing 106
Jacksonville 98
Nyköping 90
Dublin 80
Los Angeles 72
Helsinki 66
Ho Chi Minh City 64
London 64
Council Bluffs 61
Chicago 58
Hefei 58
Dallas 57
New York 47
Hanoi 42
Modena 40
Lauterbourg 37
The Dalles 36
Izmir 35
San Diego 32
Seoul 31
Munich 30
Princeton 25
Eugene 22
Jakarta 22
Salt Lake City 22
Sofia 22
São Paulo 21
Bremen 20
Shanghai 19
Moscow 16
Frankfurt am Main 15
Sydney 15
Dong Ket 14
Haiphong 14
Montreal 14
Orem 14
Brussels 12
Buffalo 12
Fremont 12
Falls Church 11
Phoenix 11
Redwood City 11
Rome 10
Turku 10
Warsaw 10
Bologna 9
Bắc Giang 8
Chennai 8
Da Nang 8
Guangzhou 8
Milan 8
Tokyo 8
Boardman 7
Columbus 7
Florence 7
Philadelphia 7
Brooklyn 6
Denver 6
Dhaka 6
Johannesburg 6
Mexico City 6
Rio de Janeiro 6
San Giuliano Milanese 6
Buenos Aires 5
Casablanca 5
Elk Grove Village 5
Jeddah 5
Kuala Lumpur 5
Kunming 5
Manchester 5
Palermo 5
Paris 5
Santiago 5
Tampa 5
Barcelona 4
Belo Horizonte 4
Bragança Paulista 4
Budapest 4
Cape Town 4
Caracas 4
Hounslow 4
Katowice 4
Lahore 4
Lappeenranta 4
Las Vegas 4
Totale 5.217
Salva come PNG Salva come JPEG
Nome #
A rapid genetic counselling and testing in newly diagnosed breast cancer is associated with high rate of risk-reducing mastectomy in BRCA1/2-positive italian women 466
Neoadjuvant treatments in triple-negative breast cancer patients: where we are now and where we are going 386
Genomic alterations at the basis of treatment resistance in metastatic breast cancer: Clinical applications 354
Collective evidence supports neutrality of BRCA1 V1687I, a novel sequence variant in the conserved THV motif of the first BRCT repeat 348
Double heterozygosity for BRCA1 and hMLH1 gene mutations in a 46-year-old woman with five primary tumors 341
Ovarian cancer: can proteomics give new insights for therapy and diagnosis? 333
Molecular mechanisms of PARP inhibitors In BRCA-related ovarian cancer 332
Clinical and molecular predictors of long-term response in HER2 positive metastatic breast cancer patients. 314
MRI in high risk women: benefits and problems 299
Risk of second primary malignancy in breast cancer survivors: A nested population-based case-control study 292
Hereditary Ovarian Cancer: Not Only BRCA 1 and 2 Genes 292
MRI before initial surgery outside of clinical trials: the real world! 288
Combined Hormonal Contraceptive Use and Risk of Breast Cancer in a Population of Women With a Family History 288
Evaluation of Transvaginal Ultrasound plus CA-125 Measurement and Prophylactic Salpingo-Oophorectomy in Women at Different Risk Levels of Ovarian Cancer: The Modena Study Group Cohort Study 282
Molecular Biomarkers for Prediction of Targeted Therapy Response in Metastatic Breast Cancer: Trick or Treat? 281
Reproductive risk factors in women with family history of breast cancer attending an Italian Family Cancer Clinic 280
Tumor size, node status, grading, HER2 and estrogen receptor status still retain a strong value in patients with operable breast cancer diagnosed in recent years. 272
The Association between Endometriomas and Ovarian Cancer: Preventive Effect of Inhibiting Ovulation and Menstruation during Reproductive Life 272
FANCM c.5791C>T nonsense mutation (rs144567652) induces exon skipping, affects DNA repair activity and is a familial breast cancer risk factor 262
Acceptability and adherence in a chemoprevention trial among women at increased risk for breast cancer attending the modena familial breast and ovarian cancer center (Italy) 251
STRATEGIES TO PREDICT TREATMENT RESPONSE AND SELECT THERAPIES IN METASTATIC BREAST CANCER PATIENTS USING A NEXT GENERATION SEQUENCING MULTI-GENE PANEL 244
Outcome evaluation in pre-trastuzumab era between different breast cancer phenotypes: a population-based study on italian women 227
DCE-MRI Radiomic analysis in triple negative ductal invasive breast cancer. Comparison between BRCA and not BRCA mutated patients: Preliminary results 169
Anthracycline-related cardiotoxicity in patients with breast cancer harboring mutational signature of homologous recombination deficiency (HRD) 122
Re: Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness 104
Characterization of copy number variants in hereditary cancer patients through NGS shows a distinctive PALB2 contribution to the diagnostic yield 83
The "popcorn" sign: the first early ultrasound sign of serous intra-parenchymal ovarian cancer in BRCA mutation carriers 58
Time to next treatment to evaluate the therapeutic sequence after first- or second-line CDK4/6 inhibitors of hormone receptor-positive, HER2-negative advanced breast cancer in Italy: a retrospective/prospective observational trial GOIRC-04-2019 51
Impact of Ethnicity on Breast Cancer Outcome: A Systematic Review and Meta-Analysis of Randomized Phase III Trials of the Last Decade. 38
Real-world effectiveness of PARP inhibitors after CDK4/6 inhibitor therapy in BRCA-mutated HR-positive/HER2-negative advanced breast cancer 17
Totale 7.346
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.958
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.958
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021187 0 0 0 0 0 0 0 0 0 85 40 62
2021/2022514 26 44 70 25 20 34 18 22 52 49 98 56
2022/2023625 76 75 36 70 66 70 7 52 137 4 19 13
2023/2024380 29 23 25 24 81 25 47 54 14 7 11 40
2024/20251.137 31 8 31 56 222 161 101 81 119 39 118 170
2025/20262.184 176 66 191 220 383 192 320 136 268 232 0 0
Totale 7.346